| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |